Louis C. Bock, Director, 10% Owner at Orexigen Therapeutics, Inc. (OREX), sold 100 shares at $15.00 ($2K) on 2007-11-21, disclosed to the SEC on 2007-11-21.
Open-market sale of $2k OREX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OREX | BUY | 2014-11-13 | $151K | — | Filing → |
| ZGNX | BUY | 2011-09-22 | $2.5M | — | Filing → |
| HZNP | BUY | 2011-08-04 | $2.8M | — | Filing → |